Objective. To compare plasma catecholamine concentrations between coca
ine-exposed and unexposed term newborns and to determine the relations
hip between plasma catecholamines and newborn behavior. Methods. Forty
-six newborn infants participating in a prospective study of the neona
tal and long-term effects of prenatal cocaine exposure were studied. B
ased on maternal self-report, maternal urine screening, and infant mec
onium analysis, 24 infants were classified as cocaine-exposed and 22 a
s unexposed. Between 24 and 72 hours postpartum, plasma samples for no
repinephrine (NE), epinephrine, dopamine, and dihydroxyphenylalanine a
nalysis were obtained. The Neonatal Behavioral Assessment Scale was ad
ministered at 1 to 3 days of age and at 2 weeks of age by examiners ma
sked to the drug exposure status of the newborns. Results. The cocaine
-exposed newborns had increased plasma NE concentrations when compared
to the unexposed infants (geometric mean, 923 pg/mL vs 667 pg/mL). Th
ere were no significant differences in plasma epinephrine, dopamine, o
r dihydroxyphenylalanine concentrations. Analysis for the effect of po
tential confounding variables revealed that maternal marijuana use was
also associated with increased plasma NE, although birth weight, gend
er, and maternal use of alcohol or cigarettes were not. Geometric mean
plasma NE was 1164 pg/mL in those infants with in utero exposure to b
oth cocaine and marijuana compared to 812 pg/mL in those exposed to on
ly cocaine and 667 pg/mL in those exposed to neither. Among the cocain
e-exposed infants, plasma NE concentration correlated with an increase
d score for the depressed cluster (r = .53) and a decreased score for
the orientation cluster (r = -.43) of the Neonatal Behavioral Assessme
nt Scale administered at 1 to 3 days of age. Adjusting for marijuana e
xposure had no effect on these relationships between plasma NE and the
depressed and orientation clusters. Conclusion. Plasma NE is increase
d in newborns exposed to cocaine and marijuana. Increased plasma NE is
associated with selected neurobehavioral disturbances among cocaine e
xposed infants at 1 to 3 days of life but not at 2 weeks.